Expression and prognostic roles of PABPC1 in esophageal cancer: Correlation with tumor progression and postoperative survival

Oncology Reports

Volumn 15, Issue 3, 2006, Pages 667-671

  Takashima, Nobuhiro ^a   Ishiguro, Hideyuki ^a   Kuwabara, Yoshiyuki ^a   Kimura, Masahiro ^a   Haruki, Nobuhiro ^a   Ando, Takuya ^a   Kurehara, Hiroki ^a   Sugito, Nobuyoshi ^a   Mori, Ryota ^a   Fujii, Yoshitaka ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Cytoplasmic 1; Esophageal cancer; Poly A binding protein; Prognosis

Indexed keywords

MESSENGER RNA; POLYADENYLIC ACID BINDING PROTEIN;

AGED; ARTICLE; DISEASE COURSE; ESOPHAGUS TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL;

AGED; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; POLY(A)-BINDING PROTEIN I; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL ANALYSIS;

EID: 33645728429     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.15.3.667     Document Type: Article

References (27)

1. Maesawa C, Tamura G, Suzuki Y, Ogasawara S, Ishida K, Saito K and Satodate R: Aberrations of tumor-suppressor genes (p53, apc, mcc and Rb) in esophageal squamous cell carcinoma. Int J Cancer 57: 21-25, 1994. (Pubitemid 24117094)
2. Nishiwaki T, Daigo Y, Kawasoe T and Nakamura Y: Isolation and mutational analysis of a novel human cDNA, DEC1 (deleted in esophageal cancer 1), derived from the tumor suppressor locus in 9q32. Genes Chromosomes Cancer 27: 169-176, 2000. (Pubitemid 30030315)
3. Miyake S, Nagai K, Yoshino K, Oto M, Endo M and Yuasa Y: Point mutations and allelic deletion of tumor suppressor gene DCC in human esophageal squamous cell carcinomas and their relation to metastasis. Cancer Res 54: 3007-3010, 1994. (Pubitemid 24187788)
4. Daigo Y, Nishiwaki T, Kawasoe T, Tamari M, Tsuchiya E and Nakamura Y: Molecular cloning of a candidate tumor suppressor gene, DLC1, from chromosome 3p21.3. Cancer Res 59: 1966-1972, 1999. (Pubitemid 29186173)
5. Japanese Society For Esophageal Diseases: Prognostic significance of cyclin D1 and E-cadherin in patients with esophageal squamous cell carcinoma: multi-institutional retrospective analysis. Research Committee on Malignancy of Esophageal Cancer. J Am Coll Surg 192: 708-718, 2001.
6. Souza RF, Garrigue-Antar L, Lei J, Yin J, Appel R, Vellucci VF, Zou TT, Zhou X, Wang S, Rhyu MG, Cymes K, Chan O, Park WS, Krasna MJ, Greenwald BD, Cottrell J, Abraham JM, Simms L, Leggett B, Young J, Harpaz N, Reiss M and Meltzer SJ: Alterations of transforming growth factor-beta 1 receptor type II occur in ulcerative colitis-associated carcinomas, sporadic colorectal neoplasms, and esophageal carcinomas, but not in gastric neoplasms. Hum Cell 9: 229-236, 1996.
7. Kawakami K, Brabender J, Lord RV, Groshen S, Greenwald BD, Krasna MJ. Yin J, Fleisher AS, Abraham JM, Beer DG, Sidransky D, Huss HT, Demeester TR, Eads C, Laird PW, Ilson DH, Kelsen DP, Harpole D, Moore MB, Danenberg KD, Danenberg PV and Meltzer SJ: Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. J Natl Cancer Inst 92: 1805-1811, 2000.
8. Kato J, Kuwabara Y, Mitani M, Shinoda N, Sato A, Toyama T, Mitsui A, Nishiwaki T, Moriyama S, Kudo J and Fujii Y: Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer 95: 92-95, 2001. (Pubitemid 32187079)
9. Shimada Y, Imamura M, Shibagaki I, Tanaka H, Miyahara T, Kato M and Ishizaki K: Genetic alterations in patients with esophageal cancer with short- and long-term survival rates after curative esophagotomy. Ann Surg 226: 162-168, 1997. (Pubitemid 28047538)
10. Lazaris-Karatzas A, Montine KS and Sonenberg N: Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5' cap. Nature 345: 544-547, 1990.
11. Samuel CE: The eIF-2 alpha protein kinases, regulators of translation in eukaryotes from yeasts to humans. J Biol Chem 268: 7603-7606, 1993.
12. Meurs EF, Galabru J, Barber GN, Katze MG and Hovanessian AG: Tumor suppressor function of the interferoninduced double-stranded RNA-activated protein kinase. Proc Natl Acad Sci USA 90: 232-236, 1993. (Pubitemid 23010284)
13. Wells SE, Hillner PE, Vale RD and Sachs AB: Circularization of mRNA by eukaryotic translation initiation factors. Mol Cell 2: 135-140, 1998. (Pubitemid 128378975)
14. Tharun S and Parker R: Targeting an mRNA for decapping: displace-ment of translation factors and association of the Lsm1p-7p complex on deadenylated yeast mRNAs. Mol Cell 8: 1075-1083, 2001. (Pubitemid 34031809)
15. Sachs AB and Davis RW: The poly (A) binding protein is required for poly (A) shortening and 60S ribosomal subunit-dependent translation initiation. Cell 58: 857-867, 1989. (Pubitemid 19227896)
16. Sachs AB and Deardorff JA: Translation initiation requires the PAB-dependent poly (A) ribonuclease in yeast. Cell 70: 961-973, 1992.
17. Japanese Society for Esophageal Disease: Guidelines for the clinical and pathologic studies on carcinoma of the esophagus. 9th edition. Tokyo Kanehara Public Co., 1999.
18. Sachs A: Physical and functional interactions between the mRNA cap structure and the poly (A) tail. In: Translational Control of Gene Expression. Sonenberg N, et al (eds). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp447-465, 2000.
19. Schwartz DC and Parker R: Interaction of mRNA degradation in Saccharomyces cerevisiae. In: Translational Control of Gene Expression. Sonenberg N, et al (eds). Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp807-825, 2000.
20. Grosset C, Chen CY, Xu N, Sonenberg N, Jacquemin-Sablon H and Shyu AB: A mechanism for translationally coupled mRNA turnover: interaction between the poly(A) tail and a c-fos RNA coding determinant via a protein complex. Cell 103: 29-40, 2000.
21. Garnis C, Coe BP, Ishkanian A, Zhang L, Rosin MP and Lam WL: Overexpression of LRP12, a gene contained within an 8q22 amplicon identified by high-resolution array CGH analysis of oral squamous cell carcinomas. Oncogene 23: 2582-2586, 2004. (Pubitemid 38520756)
22. Miyazaki S, Imatani A, Ballard L, Marchetti A, Buttitta F, Albertsen H, Nevanlinna HA, Gallahan D and Callahan R: The chromosome location of the human homolog of the mouse mammary tumor-associated gene INT6 and its status in human breast carcinomas. Genomics 46: 155-158, 1997. (Pubitemid 27527706)
23. Pabst T, Schwaller J, Bellomo MJ, Oestreicher M, Muhlematter D, Tichelli A, Tobler A and Fey MF: Frequent clonal loss of heterozygosity, but scarcity of microsatellite instability at chromosomal breakpoint cluster regions in adult leukemias. Blood 88: 1026-1034, 1996. (Pubitemid 26333328)
24. Shibata Y, Haruki N, Kuwabara, et al: Expression of pituitary tumor transforming gene in esophageal cancer. Jpn J Clin Oncol 32: 234-237, 2002.
25. Terashita Y, Sasaki H, Haruki N, et al: Decreased peroxisome proliferator-activated receptor gamma gene expression is correlated with poor prognosis in patients with esophageal cancer. Jpn J Clin Oncol 32: 238-243, 2002. (Pubitemid 43102806)
26. Konishi S, Ishiguro H, Shibata Y, et al: Decreased expression of DFF45/ICAD is correlated with a poor prognosis in patients with esophageal carcinoma. Cancer 95: 2473-2478, 2002. (Pubitemid 35424031)
27. Terashita Y, Ishiguro H, Haruki N, et al: Excision repair cross complementing 3 (ERCC3) expression is involved in patient prognosis and tumor progression in esophageal cancer. Oncol Rep 12: 827-831, 2004.